Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 1.00 |
| ▸ | CCR6 | P51684 | 1/20 | 1.00 |
| ▸ | PAX8 | Q06710 | 1/20 | 1.00 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 1.00 |
| ▸ | NR4A1 | P22736 | 7/20 | 0.84 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.83 |
| ▸ | CASP1 | P29466 | 1/20 | 0.83 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.83 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.83 |
| ▸ | TP53 | P04637 | 1/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.83 |
| ▸ | MAPT | P10636 | 1/20 | 0.83 |
| ▸ | HPGD | P15428 | 1/20 | 0.83 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.83 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.83 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.83 |
| ▸ | TERT | O14746 | 7/20 | 0.82 |
| ▸ | HSP90AB1 | P08238 | 5/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Celastrol SCHEMBL17130559 | 1.00 | HSP90AA1 (1.00) | HSP90AA1CCR6PAX8TLR9NR4A1 | |
| Celastrol SCHEMBL25510440 | 1.00 | HSP90AA1 (1.00) | HSP90AA1CCR6PAX8TLR9NR4A1 | |
| Celastrol SCHEMBL15813281 | 1.00 | HSP90AA1 (1.00) | HSP90AA1CCR6PAX8TLR9NR4A1 | |
| Celastrol SCHEMBL19745423 | 1.00 | HSP90AA1 (1.00) | HSP90AA1CCR6PAX8TLR9NR4A1 | |
| Celastrol SCHEMBL17430781 | 1.00 | HSP90AA1 (1.00) | HSP90AA1CCR6PAX8TLR9NR4A1 | |
| Celastrol SCHEMBL18845540 | 1.00 | HSP90AA1 (1.00) | HSP90AA1CCR6PAX8TLR9NR4A1 | |
| Celastrol SCHEMBL20547678 | 0.99 | HSP90AA1 (0.98) | HSP90AA1CCR6PAX8TLR9NR4A1 | |
| SCHEMBL12395103 | 0.93 | HSP90AA1 (0.86) | HSP90AA1CCR6PAX8TLR9NR4A1 | |
| SCHEMBL13287257 | 0.92 | HSP90AA1 (0.86) | HSP90AA1CCR6PAX8TLR9NR4A1 | |
| Celastrol SCHEMBL23777521 | 0.92 | HSP90AA1 (0.84) | HSP90AA1CCR6PAX8TLR9NR4A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4175 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075411-A | Tripterine liposome, its combined medicine and its application in preventing and treating tumor | — | 2026-05-26 | — | — | CN | claimed |
| CN-117241814-B | Combination of myrtle extract and tripterygium wilfordii extract for controlling inflammation caused by propionibacterium acnes | 皮埃尔·法布尔皮肤化妆品公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122005588-A | Pharmaceutical composition containing evodiaoside, drug carrying system and application thereof in osteoarthritis | 江苏省中医药研究院(江苏省中西医结合医院) | 2026-05-12 | — | — | CN | claimed |
| US-20260124224-A1 | USE OF COMBINED COMPOSITION IN PREPARING DRUG FOR RESISTING FUNGAL AND BACTERIAL INFECTIONS | NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY (CN) | 2026-05-07 | — | — | US | claimed |
| WO-2026087695-A1 | TREATMENT FOR METABOLIC DISORDER | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| WO-2026087680-A1 | TREATMENT FOR CARDIOVASCULAR DISEASE | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| EP-4724065-A1 | SYNERGISTIC COMPOSITION FOR MODULATING EXPRESSION OF CD38 | Celagenex Research (India) Pvt. Ltd. (IN) | 2026-04-15 | — | — | EP | claimed |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4479072-B1 | COMPOSITION COMPRISING A MYRTLE EXTRACT AND A TRIPTERYGIUM WILFORDII EXTRACT FOR CONTROLLING ACNE OF NON-LESIONAL AREAS OF ACNEIC SKIN | PIERRE FABRE DERMO COSMETIQUE (FR) | 2026-03-04 | — | — | EP | claimed |
| CN-121583384-A | Nucleic acid-small molecule non-covalent complex and preparation method and application thereof | 上海中医药大学 | 2026-02-27 | — | — | CN | claimed |
| EP-1151295-A1 | METHODS OF IDENTIFYING THERAPEUTICALLY EFFECTIVE ANTINEOPLASTIC AGENTS WITH CULTURED CELLS HAVING INTACT CELL MEMBRANES AND CORRESPONDING PRODUCTS | Cytovia, Inc. (US) | 2001-11-07 | — | — | EP | claimed |
| EP-1098626-A2 | METHOD FOR REGULATING HAIR GROWTH | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER (US) | 2001-05-16 | — | — | EP | claimed |
| WO-2000066080-A1 | ANTI-DANDRUFF AND CONDITIONING SHAMPOOS CONTAINING CERTAIN CATIONIC POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-09 | — | — | WO | claimed |
| WO-2000066081-A1 | ANTI-DANDRUFF AND CONDITIONING SHAMPOOS CONTAINING POLYALKYLENE GLYCOLS AND CATIONIC POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-09 | — | — | WO | claimed |
| US-6124362-A | TOPICAL ADMINISTRATION OF LUPANE TRITERPENES, DERIVATIVES OF LUPANE TRITERPENES, DERIVATIVES OF OLEANANE TRITERPENES, DERIVATIVES OF URSANE TRITERPENES, AND SALTS | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-26 | — | — | US | claimed |
| WO-2000045165-A1 | METHODS OF IDENTIFYING THERAPEUTICALLY EFFECTIVE ANTINEOPLASTIC AGENTS WITH CULTURED CELLS HAVING INTACT CELL MEMBRANES AND CORRESPONDING PRODUCTS | CYTOVIA, INC. (US) | 2000-08-03 | — | — | WO | claimed |
| WO-2000003749-A2 | METHOD FOR REGULATING HAIR GROWTH | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER (US) | 2000-01-27 | — | — | WO | claimed |
| US-5880116-A | ORAL ADMINISTRATION OF CELASTROL OR ESTER PRODRUG | NEUROCAL INTERNATIONAL (US) | 1999-03-09 | — | — | US | claimed |
| WO-1998025573-A2 | THE USE OF CELASTROL TO TREAT ALZHEIMER'S DISEASE | NEUROCAL INTERNATIONAL (US) | 1998-06-18 | — | — | WO | claimed |
| US-4328309-A | EXTRACTS FROM THE LEAVES OF TRIPTERYGIUM | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 1982-05-04 | — | — | US | claimed |